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One of the most common pathologies in aging humans is the development of glucose metabolism dysfunction.
The high incidence of metabolic dysfunction, in particular type 2 diabetes mellitus, is a significant health and
economic burden on the aging population. However, the mechanisms that regulate this age-related physiological
decline, and thus potential preventative treatments, remain elusive. Even after accounting for age-related
changes in adiposity, lean mass, blood lipids, etc., aging is an independent factor for reduced glucose tolerance
and increased insulin resistance. Oxidative stress has been shown to have significant detrimental impacts on
the regulation of glucose homeostasis in vitro and in vivo. Furthermore, oxidative stress has been shown to
be modulated by age and diet in several model systems. This review provides an overview of these data and
addresses whether increases in oxidative stress with aging may be a primary determinant of age-related
metabolic dysfunction.
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Introduction
The aging process is associated with functional declines
in nearly every physiological parameter measured to date
[1]. One of the most common physiological declines in
human aging is a general deficit in the ability to effect-
ively regulate glucose metabolism. The prevalences of
elevated fasting glucose levels, glucose intolerance, and
insulin resistance have all been shown to be significantly
elevated in the aged population [2-5]. Indeed, one of the
most common diseases of the elderly is type 2 diabetes
mellitus. The NIH estimated that in 2010 approximately
4% of people aged 20–44 in the United States were
affected by type 2 diabetes; in contrast, in this same
period 26.9% of people older than 65, or 11 million
Americans, were suffering from this disease. Determin-
ing how aging so powerfully affects the progression
of this disease could lead to potential prevention and
reduction in the aged population.Correspondence: salmona@uthscsa.edu
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reproduction in any medium, provided the orAging in mammals is generally associated with accu-
mulating adipose tissue, diminishing lean mass and ele-
vated blood lipids, all of which are associated with the
development of insulin resistance. Even after controlling
for these confounds, aging alone is an independent fac-
tor in the declining response to insulin in skeletal
muscle and other tissues [6-8]. In a longitudinal study of
over 4,500 healthy individuals, Lindstrom et al. showed
the likelihood of patients 55–64 years of age for develop-
ing drug-treated diabetes was roughly equivalent to
patients with a BMI >30 [9]. In other words, clinical
obesity and advanced age present nearly the same risk of
causing metabolic dysfunction. This is particularly wor-
risome when considering that several diabetes risk fac-
tors (obesity, hyperglycemia, etc.) have straightforward
treatment options whereas aging is a persistent, un-
yielding process. The mechanisms that regulate the
effects of aging on glucose metabolism have not yet
been clearly identified. Recent evidence has suggested
that oxidative stress may be an important factor in this
process. The Oxidative Stress Theory of Aging has been
one of the most prominent mechanistic theories on how
the aging process is regulated. Most studies in this field
have shown little effect of oxidative stress on mamma-
lian lifespan, but there is clear evidence that oxidativeThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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related diseases and pathologies [10].
Oxidative stress is a necessary byproduct of life in
aerobic environments. Oxygen free radicals are gener-
ated through several cellular processes, the most signifi-
cant of which occurs with aerobic respiration in the
mitochondria. In the presence of molecular oxygen, the
reactions that generate ATP in the electron transport
chain complexes of the mitochondria can generate oxy-
gen free radicals [11]. However, aerobic organisms have
evolved a complex antioxidant defense system to reduce
free radicals, prevent oxidative damage, and repair oxi-
dative damage that does occur [10]. An exhaustive
review of all cellular pro-oxidant and antioxidant sources
are beyond the scope of this review. At the most basic
level, oxidative stress occurs under conditions that favor
factors that generate oxygen free radicals (pro-oxidants)
rather than those factors that evolved to reduce these
radicals (antioxidants). In contrast, conditions that
favor reduction of free radicals, for example by in-
creasing cellular antioxidants, would be predicted to
reduce oxidative stress under normal physiological
conditions. The remainder of this review will provide
support for the hypothesis that age-dependent altera-
tions in this balance promote oxidative stress which
causes metabolic dysfunction.
Oxidative stress causes metabolic dysfunction
Several studies have shown that oxidative stress can dir-
ectly promote cellular insulin resistance and alter glucose
metabolism. In cell culture, oxidative stress dramatically
decreases the cellular response to insulin. In these stud-
ies, treatment with oxidative stress significantly reduced
insulin-stimulated glucose uptake, reduced phosphoryl-
ation of the downstream insulin signaling mediators pro-
tein kinase B (AKT), insulin receptor substrate protein-1
(IRS-1), and glycogen synthase kinase-3, and reduced glu-
cose transporter (GLUT4) translocation to the cellular
membrane [12-16]. Similarly, glucose transport was
reduced in ex vivo rat muscle following oxidative stress
[17,18]. Chronic H2O2 treatment of ex vivo muscle also
inhibited insulin-stimulated phosphorylation of the insu-
lin receptor and AKT and caused a selective loss of IRS
proteins which further inhibited insulin response [18].
Furthermore, treatment with antioxidants prevented the
development of insulin resistance in both cell culture
and ex vivo experimental models [15,16,18]. Antioxidants
also partially prevented cellular insulin resistance caused
by tumor necrosis factor-alpha (TNFα), glucocorticoids,
and the saturated fatty acid palmitic acid, suggesting that
oxidative stress plays a key role in their action on glucose
metabolism [19,20]. Together, these data show that oxi-
dative stress can both directly and indirectly inhibit glu-
cose metabolism.There is also strong evidence that elevated levels of
oxidative stress are correlated with defects in glucose
metabolism in both human clinical studies and labora-
tory models. For example, urinary levels of the DNA
oxidation marker 8-oxo-2'-deoxyguanosine (8-OHdG)
and plasma levels of the lipid oxidation marker
malondialdehyde (MDA) are significantly elevated in
diabetic patients [21-23]. One interpretation of this is
that hyperglycemia with metabolic dysfunction may
promote oxidative stress [24,25]. However, even pre-
diabetic patients show elevated urinary levels of 8-
OHdG suggesting that oxidative stress may precede the
clinical development of glucose intolerance, insulin re-
sistance and diabetes [26]. Similarly, Tinahones et al.
found the degree of insulin resistance among obese
patients was positively correlated with plasma lipid per-
oxidation levels and inversely correlated with plasma
antioxidant levels [27]. Furthermore, defects in glucose
metabolism are associated with both reduced levels of
antioxidants (glutathione and vitamin E and C) as well
as reduced activity of antioxidants (superoxide dismu-
tase, glutathione peroxidase, and glutathione reductase)
in plasma [27-32]. Together, these findings hint that
oxidative stress may act as both cause and effect of
metabolic dysfunction in a vicious cycle towards devel-
oping diabetes.
Though there is a clear association between oxidative
stress and the pathological state of diabetes (or pre-
diabetes), the association between oxidative stress and age-
induced metabolic dysfunction is less clear. Samiec et al.
reported that plasma levels of the antioxidant glutathione
from healthy individuals older than 60 years are greater than
those of younger diabetics but less than those of healthy
younger individuals [30]. Interestingly, this study also
reported that levels of the oxidized form of glutathione
(GSSG) were relatively high in both healthy older and dia-
betic individuals [30]. Similarly, Nuttal et al. found that
plasma lipid hydroperoxide levels were highest in elderly
diabetics (~75 years old) followed by healthy elderly
(~70 years old) with the lowest levels were reduced in
healthy young individuals [33]. This study also showed total
antioxidant capacity and glutathione levels were reduced in
both elderly diabetics and healthy elderly compared to
healthy young [33]. Mendoza-Nunez et al. showed that both
diabetes and aging are risk factors for increased oxidative
stress with an additive effect of both phenotypes [34]. Even
among diabetic patients, markers of plasma oxidative stress
significantly increase with age [35]. This trend is also evident
in laboratory mice; Wu et al. found that protein oxidation
and activation of oxidative stress-sensitive pathways were
elevated in both young diabetic and old mice and elevated
further still in old diabetic mice [36]. Examining whether
oxidative stress and/or damage is associated with mild age-
related metabolic defects, rather than frank diabetes, is an
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review.
Oxidative stress accumulates with age in tissues that
regulate glucose metabolism
Glucose metabolism in mammals is regulated by a com-
plex set of endocrine signals that ultimately affect insulin
release from the pancreas, glucose production from the
liver, and glucose uptake in peripheral tissues including
skeletal muscle, adipose, liver, brain, and cardiac muscle.
Development of insulin resistance in skeletal muscle,
white adipose tissue, and liver is generally thought to be
the primary etiology of glucose metabolism dysfunction.
The insulin response in each of these tissues shows a
significant decline with age [2,3,37]. If oxidative stress
is a significant contributor to this process, it would be
predicted that elevated levels of oxidative stress/damage
in these tissues would be associated with 1) metabolic
dysfunction and 2) increasing age.
As discussed above, there is strong evidence supporting
the first prediction; that is, circulating levels of
oxidative stress are generally elevated in vivo in experi-
mental models of metabolic dysfunction. There is also
strong evidence for increased oxidative stress in the tissues
of these models. Obesity, whether caused by genetic fac-
tors or high fat/high caloric diets, diminishes insulin sensi-
tivity and increases oxidative stress in rodents and humans
[38]. For example, skeletal muscle and adipose tissue of
high-fat-fed laboratory mice show high levels of protein
oxidation as measured by total levels of proteins bound
with carbonyl or 4-HNE (4-hydroxenonal) adducts [39,40].
Similarly, lipid oxidation levels are also elevated in these
tissues from high fat fed mice and rats [38,41]. Moreover,
skeletal muscle mitochondria production of superoxide
and hydrogen peroxide is significantly increased with high
fat feeding [42,43] as is superoxide production from
NADPH oxidase activity in adipose tissue [38]. There is
limited data on oxidative stress/damage in tissues from
human subjects due to the challenges in obtaining sam-
ples. However, obesity in humans is associated with
increased protein oxidation adducts in subcutaneous adi-
pose tissue and skeletal muscle [44,45]. Together, these
findings show that reduction in glucose metabolism in
rodents and humans is strongly associated with oxidative
stress.
Since the development of the Oxidative Stress The-
ory of Aging over 50 years ago, there have been exten-
sive efforts to address whether accumulating oxidative
damage (including that in muscle, liver and adipose
tissue) is a significant modulator of the aging process
[46]. Old mice do have increased levels of DNA, lipid
and protein oxidation in skeletal muscle [47-49] and
mitochondria from muscles of old mice produce more
hydrogen peroxide than those from young mice [47].Similarly, muscle biopsies from healthy older human
subjects show increased levels of lipid peroxidation and
reduced levels of several antioxidants [50]. Liver and vis-
ceral adipose have also been reported to accumulate lipid
and protein oxidative damage with age in both mice and
rats [48,51-55].
Oxidative stress might also negatively affect glucose me-
tabolism at the level of insulin release from the β-cells of
the pancreas. In comparison to other tissues, the relative
expressions of the antioxidants superoxide dismutases
(both the cytosolic Cu/Zn SOD and mitochondrial Mn
SOD), glutathione peroxidases, and catalase are reduced
in islet cells [56,57]. A blunted antioxidant defense may be
beneficial in these cells because reactive oxygen species
are required for normal β-cell response to glucose
[58,59]. However, this phenotype also renders pancreatic
β-cells particularly sensitive to the negative effects of oxida-
tive stress. For example, streptozotocin, a toxin selective to
β-cells used to create diabetic rodents, works in part by
generating oxidative stress [60,61]. Several antioxidant
treatments have been shown to prevent streptozotocin-
induced β-cell death [60-62]. Furthermore, genetic overex-
pression of antioxidants has been shown to protect the
pancreas in diabetic models [63]. While the effect of aging
on oxidative damage in the pancreatic cells has not yet
been addressed, there are several reports of increased oxi-
dative damage in this tissue with metabolic dysfunction
[60,61,64,65].
It is likely that all tissues are targets of oxidative dam-
age in metabolic dysfunction and/or aging; however,
there is evidence that adipose may be more susceptible
to, or generate more, oxidative stress than others. Until
recently, white adipose tissue was thought to be a largely
inert, energy storing tissue. However, adipose tissue is a
dynamic endocrine organ and changes in its function may
play a significant role in the aging process in mammals
[66]. White adipose tissue, particularly visceral adipose, is
characterized as highly inflammatory. Aging significantly
increases the production of proinflammatory cytokines
from macrophages and pre-adipocytes in this tissue [67-
69]. Our own data show that oxidative damage is higher
in visceral adipose than either skeletal muscle or liver even
at a young age. Levels of lipid peroxidation (measured by
F2-isoprostanes) in young male C57BL/6 mice were more
than two-fold higher in visceral adipose compared
to muscle and liver (Figure 1). Levels of protein oxidation
(measured by methionine sulfoxides) in adipose
tissue were also significantly greater than in muscle or
liver (Figure 1). Furthermore, modulation of oxidative
stress in this tissue is extremely responsive to environ-
mental conditions. Induction of metabolic stress by high
fat feeding dramatically increased both of these markers in
adipose tissue with more modest changes in both muscle
and liver (Figure 1).
Figure 1 High oxidative stress in mouse adipose tissue. Levels
of F2-isoprostanes (top) and methionine sulfoxides (bottom) in
young male C57BL/6 mice. Bars represent mean levels of indicated
oxidation moiety (± SEM) from four animals for each indicated
measurement. Samples shown represent epididymal depot/visceral
fat (adipose tissue), quadriceps (skeletal muscle), and liver. Dashed
line indicates mean value for adipose tissue in low-fat (normal)-fed
animals. High-fat diet animals were fed a defined diet with 45% kCal
from fat (Research Diets D12451P) for 16 weeks. Isoprostanes were
measured as previously described [70]. Methionine sulfoxides
were measured by immunoblot using methionine sulfoxide from
Oxford Biochemical.
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dysfunction?
Oxidative stress may exert its effects on glucose meta-
bolism through three primary pathways: (1) by activation
of stress-responsive signaling pathways, (2) by promo-
tion of proinflammation and (3) by directly affecting the
insulin signaling pathway. For the purposes of this re-
view, these pathways have largely been studied for their
effect on reduction of insulin signaling. For
example, activation of the c-jun N terminal kinase (JNK)
signaling pathway has been implicated in the etiology of
diabetes and insulin resistance, particularly that caused
by obesity [71]. Activation of JNK, in particular theJNK1 isoform, phosphorylates IRS-1 at sites that prevent
its recruitment to the activated insulin receptor thus
preventing propagation of insulin signaling and promot-
ing insulin resistance [72,73]. Oxidative stress can acti-
vate JNK signaling both directly and indirectly through
several kinase pathways [74-76]. JNK activation is signifi-
cantly upregulated in obesity and metabolic dysfunction;
further, genetic ablation of JNK in mice (either whole
body or liver-specific) prevents dietary- and genetically-
induced insulin resistance [77,78]. Several tissues have
been reported to show elevated JNK activation with
aging in both rodents and humans [79,80].
Chronic inflammation has been proposed to signifi-
cantly influence the progression of several age-related
diseases and pathologies, including the decline in glu-
cose metabolism homeostasis [71,81,82]. Oxidative stress
promotes the production of several pro-inflammatory
cytokines including interleukin-6 (IL-6) and monocyte
chemotactic protein in cells [83]. Oxidative stress can
also activate nuclear factor κB (NfκB), a transcription
factor that regulates production of TNFα and IL-6
[84,85]. Oxidative stress also promotes cellular senes-
cence, particularly in adipocytes; these senescent cells can
then promote localized inflammation by secreting pro-
inflammatory cytokines and by recruiting macrophages
[86-88]. TNFα and IL-6 have been shown to inhibit insu-
lin signaling through inhibitory phosphorylation of IRS1;
ablation of these cytokines prevents insulin resistance in
cells and in vivo [89,90]. Aging is a significant factor in
the increased expression of multiple proinflammatory
cytokines including TNFα and IL-6 [67,91]. Furthermore,
aging has been shown to prevent the normal suppression
of TNFα that occurs postprandially [92].
It is also possible that oxidative stress may directly
cause insulin resistance by damaging cellular compo-
nents required for proper insulin signaling. Oxidative
stress impairs binding of insulin to the insulin receptor
and reduces cellular internalization of insulin, presum-
ably by promoting oxidative damage at its binding site
[93]. Similarly, Zhou et al. and Van den Dobbelsteen
et al. showed that high doses of peroxynitrite or redox-
cycling agents can inhibit the ability of insulin receptor
to undergo autophosphorylation [94,95]. Oxidative stress
disrupts the insulin-stimulated cellular redistribution of
IRS1 and phosphoinositide 3-kinase required for effi-
cient transduction of insulin signaling, GLUT4 trans-
location and glucose uptake [96]. In addition, GLUT4
levels decrease with oxidative stress because of oxidative
damage to nuclear proteins regulating its expression
[97]. It has been suggested that age-associated insulin re-
sistance is partly due to diminished function of
insulin signaling proteins [98]. Proteins that undergo
oxidation have clear and marked declines in function
largely due to changes in their structural conformation
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decline in insulin signaling function can be ascribed to
this biochemical process.
Can antioxidants prevent metabolic dysfunction in vivo?
If oxidative stress is a significant cause of glucose
intolerance/insulin resistance, antioxidant treatments
would be predicted to prevent metabolic dysfunction. In
rodent models, there is substantial evidence supporting
this hypothesis. For example, treatment of mice with the
mitochondria-targeted superoxide dismutase mimetic
MnTBAP prevented the development of insulin resis-
tance and glucose intolerance caused by high fat diet
feeding [101]. MnTBAP treatment also improved glucose
homeostasis in genetically obese mice [19]. Rats treated
with a different mitochondria-targeted small molecule
antioxidant, SS31, showed a similar protection from
high fat diets [42]. Several genetic models of increased
antioxidant expression have also been shown to protect
from obesity-induced insulin resistance; overexpression
of Mn-superoxide dismutase, catalase (specifically in
mitochondria; mCAT) and peroxiredoxin 3 have all been
shown to preserve glucose homeostasis with high fat
feeding [42,101,102]. Antioxidant treatments have also
been suggested to prevent age-associated metabolic
dysfunction in rodent models. Lee et al. showed that
mCAT mice are protected from age-associated declines
in insulin due to due to reduced mitochondrial H2O2
production and reduced accumulation of oxidative dam-
age [103]. Long-term treatment of rats with the
antioxidants vitamin C or butylated hydroxytoluene
improved the insulin response of adipocytes isolated
from old animals [104].
Despite the strong evidence that antioxidants may be
beneficial for glucose metabolism in rodents, most stud-
ies on antioxidant therapy in humans have been largely
inconclusive. Classical antioxidant therapies, such as
vitamin C and vitamin E, appear to have little effect
on metabolic dysfunction of several forms [105]. Other
antioxidants such as coenzyme Q10, alpha-lipoic acid,
and L-carnitine have also been largely ineffective asFigure 2 Proposed model illustrating the potential links between agintreatments [106]. Because these clinical studies only
treated individuals exhibiting diabetes or pre-diabetes,
one interpretation may be that these treatments cannot
reverse metabolic dysfunction. If oxidative stress pre-
cedes the development of glucose tolerance and insulin
resistance [26], it may be more apt to utilize antioxidants
as a preventative as in many of the rodent studies above.
Furthermore, issues of dosage and bioavailability in tar-
get tissues are significant confounds in these studies
[107]. For example, because of the high lipid levels in
adipose, this highly oxidized tissue may not be strongly
affected by water-soluble antioxidants. New insights into
the mechanisms by which oxidative stress negatively
affects glucose metabolism may provide new antioxi-
dants, or treatment regimes, that can prevent age-
related metabolic dysfunction.
Conclusions
The high incidence of metabolic dysfunction in the aged
population is a significant health and economic burden
on a growing population. The population growth of both
individuals over 65 years of age and obese individuals
suggests that this problem will not diminish without sig-
nificant intervention. While improving diet, increasing
aerobic exercise and weight loss can all improve glucose
metabolism, aging remains an independent factor in the
development of insulin resistance [6-8]. Understanding
this process could significantly improve both health span
of the aging individual and health of the elderly popula-
tion. How oxidative stress may fit into this process is
summarized in Figure 2. Regulating oxidative stress does
make for an attractive treatment target; the process is
well studied, there are precise assays for its measure-
ment, and there are viable treatments, such as antioxi-
dants, that reduce its effects.
While experimental evidence has suggested that anti-
oxidant treatments can prevent metabolic dysfunction
caused by diet or aging in rodents, clinical studies have
largely failed. Some potential rationales for these dis-
crepancies have been described above. However, the
benefit of healthy diet, activity and lifestyle on reducingg, oxidative stress, and metabolic dysfunction.
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to at least slow the progression of metabolic defects
[108-113]. As mentioned above, studies in rodents sug-
gest that there may be some benefit to increasing anti-
oxidant levels as anti-diabetic prophylactic treatment
rather than clinical treatment [19,42,101]. Support would
require long-term longitudinal studies to determine
whether these treatments would be preventative. In the
short-term, new insights into the mechanisms by which
oxidative stress negatively affects glucose metabolism
may develop new antioxidants, or treatment regimes,
that can prevent age-related metabolic dysfunction. For
example, new treatments that specifically target muscle
or adipose tissue may have much stronger effects on
glucose metabolism at lower doses than more general
antioxidants. The goal of these studies should not be to
find alternatives to healthy living, but rather to utilize
treatments in conjunction with healthy lifestyles to
extend the health span in humans.
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